Researchers at the University of Kansas found high vaccine hesitancy among women leaving incarceration, a substantial and vulnerable population in the United States. However, a web-based health app proved effective at boosting the group's health literacy.
A study of nearly 550 adults with intellectual and developmental disabilities receiving residential services in New York City found that age, larger residential settings, Down syndrome and chronic kidney disease were the most common risk factors for COVID-19 diagnosis, and heart disease was most associated with COVID-19 deaths.
To gain a better understanding of SARS-CoV-2 outbreaks involving care homes with fully vaccinated residents, Charité researchers used an outbreak at a Berlin-based facility to analyze virus-related data and the immune responses of elderly residents following vaccination. The data confirm vaccine effectiveness in the elderly, but also indicate a delayed and slightly reduced immune response. The researchers emphasize the need to vaccinate both caregivers and close contacts in order to better protect this high-risk group.
Human papillomavirus (HPV) vaccines applied in national vaccination programs protect against most cancers associated with oncogenic, high-risk (hr) HPV types. Two recent studies demonstrate the impact of gender-neutral HPV vaccination in the overall protection against hrHPV infections already with low vaccination coverage.
This survey study among women with breast cancer in Mexico evaluates their specific concerns about and high hesitancy rate toward COVID-19 vaccination.
In a review published in the journal Cancer Cell of 200 patients with a wide spectrum of cancer diagnoses, researchers found that after full vaccination, 94%of patients overall demonstrated seroconversion, which was determined by the presence of antibodies to the SARS-CoV-2 spike protein. Response rates were very high among patients with solid tumors and were lower in people with certain blood cancers, but even the majority of those patients mounted an immune response.
Researchers from York University and the University of British Columbia have found social media use to be one of the factors related to the spread of COVID-19 within dozens of countries during the early stages of the pandemic. The researchers say this finding resembles other examples of social media misinformation ranging from the initial phase of vaccine rollout to the 2021 Capitol riot in the United States.
In a new study published in Nature, Dan Barouch, MD, PhD, Director of Beth Israel Deaconess Medical Center's Center for Virology and Vaccine Research, and colleagues report on the antibody and cellular immune responses generated by the Ad26.COV2.S vaccine against the original viral strain and against SARS-CoV-2 variants of concern. The team found that this vaccine induced immune responses against all the viral variants.
A condition that affects the blood, known as idiopathic thrombocytopenic purpura (ITP), may be associated the Oxford-AstraZeneca vaccine in rare cases, research suggests.
A new review published in the Journal of Internal Medicine indicates that unmasked speech in confined spaces poses the greatest risk of spreading SARS-CoV-2, the virus that causes COVID-19, to others.